Advertisement
Advertisement
U.S. markets open in 8 hours
Advertisement
Advertisement
Advertisement
Advertisement

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
44.01-0.52 (-1.17%)
As of 01:15PM CST. Market open.
Advertisement

Shenzhen Kangtai Biological Products Co., Ltd.

Science and Technology Park
No. 6, Kefa Road Nanshan District
Shenzhen 518057
China
86 755 2698 8658
https://www.biokangtai.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees2,445

Key Executives

NameTitlePayExercisedYear Born
Mr. Weimin DuChairman, Gen. Mang.N/AN/AN/A
Tong LiVPN/AN/AN/A
Qun LiuVPN/AN/AN/A
Mr. Haifa ZhengDirector, Deputy Gen. Mang.N/AN/A1964
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.

Corporate Governance

Shenzhen Kangtai Biological Products Co., Ltd.’s ISS Governance QualityScore as of July 1, 2022 is 9. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement